Serge Clotaire Billong Senior Lecturer / FMBS-UY1

Slides:



Advertisements
Similar presentations
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
Advertisements

February 2006 WHO's Contribution to Scaling Up towards Universal Access to HIV/AIDS Prevention, Care and Treatment Department of HIV/AIDS.
Outcome Framework for Health Services: Case Study of HIV/AIDS Thailand Nichawan Nuankaew.
Learning and Empowerment: “Key Issues in Strategies for HIV/AIDS Prevention” March 1-5, 2004, Chiang Mai Presented by Dr. Pum Sophiny, Program Officer.
May 18, 2015 UNAIDS Know Your Epidemic Guidelines to Enhance Knowledge on Country-Specific HIV Context to Better Support the National Response.
© Aahung 2004 Millennium Development Goals Expanding the Agenda:
RTI International RTI International is a trade name of Research Triangle Institute. What Do We Know and Where Do We Go: The State of the Field.
Comprehensive M&E Systems
Inclusion of Adolescents with Disabilities: Towards an AIDS-Free Generation All In! Rosangela Berman Bieler Senior Adviser, Children with Disabilities,
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
Concept Note on HIV Mongolia Process and key components of Funding Request to Global Fund.
“A VISION OF HOPE” EXPERIENCE OF SENEGAL IN THE FIGHT AGAINST AIDS AND REDUCING WOMEN’S VULNERABILITY Dr Khoudia Sow, CRCF, UMI 233 Dakar Sénégal.
Tajikistan The Global Fund to Fight AIDS, Tuberculosis and Malaria Support to the Strategic Plan to Prevent HIV/AIDS Epidemics in Tajikistan. November.
Unit 8: Uses and Dissemination of HIV Sentinel Surveillance Data #3-8-1.
Fundamentals of Evaluation for Public Health Programs ROBERT FOLEY, M.ED. NIHB TRIBAL PUBLIC HEALTH SUMMIT MARCH 31,
Unit 10. Monitoring and evaluation
HIV Prevention and Treatment for Men who have sex with Men: Achievements and Challenges Ifeanyi Kelly Orazulike National Coordinator Sexual Minorities.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Sri Lanka Last updated: December 2014.
HIV and AIDS Data Hub for Asia-Pacific HIV and AIDS Data Hub for Asia-Pacific Review in slides China 1.
Global Partnership on Disability and Development What is the GPDD? Presentation to JICA Group Training Course HIV/AIDS Section Judith Heumann, Lead Consultant,
Historical Mapping of HIV Programmes 1985 – 2012 in Malawi Presented at the 20 TH INTERNATIONAL AIDS CONFERENCE, MELBOURNE, AUSTRALIA 24 th July 2014 By.
Proposed Priority Actions By NSF Goals (before group work) By Rose Nalwadda 1 st February 2006.
1 DEWG meeting October 2009 Human Resource Development for TB Control (HRD-TB) Sub Group within the DEWG of the Stop TB Partnership. Wanda Walton.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
Regional Videoconference Addressing Stigma and Discrimination of HIV/AIDS in Africa Thursday, April 2, 2009 UNAIDS Perspective Susan Timberlake, Senior.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
HIV and AIDS Data Hub for Asia-Pacific Review in slides India.
India Last updated: January 2016.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Afghanistan Last updated: January 2016.
HIV/AIDS A MAJOR DEVELOPMENT CONCERN FOR THE AFRICAN DEVELOPMENT BANK March 2008.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Mongolia Last updated: December 2014.
1 The UN Perspective UNAIDS Trinidad & Tobago Tenth PANCAP Annual General Meeting, November 2, 2010 The AIDS Response in the Post-Earthquake Reconstruction.
Main achievements and further developments 2006 and beyond: Overcoming HIV/AIDS epidemic in Ukraine (programme (programme supported by the Global Fund)
HIV and AIDS Data Hub for Asia-Pacific Review in slides Sri Lanka.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Sri Lanka Last updated: April 2016.
BURUNDI PERMANENT EXECUTIVE SECRETARIAT (SEP) NATIONAL AIDS COUNCIL (C N L S) Epidemic situation and national response for prevention in Burundi PRESENTED.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
DR. THOMAS OGARO, MBCHB, MPH, PhD
Outline The Global Fund Strategy emphasizes the Key Populations
PrEP Scale Up in Kenya: Bridge to Scale Project
Sri Lanka Last updated: September 2016.
High HIV prevalence among drug injecting female sex workers in Viet Nam: The need to reduce both sexual and injection risks in this vulnerable population.
Developing reporting system for SDG and Agenda 2063, contribution of National Statistical System, issues faced and challenges CSA Ethiopia.
Timor-Leste Last updated: January 2016.
Bhutan Last updated: September 2016.
Zimbabwe’s shift towards treat all: national country context
Mongolia Last updated: April 2016.
Strengthening the Focus of Municipal HIV Responses on Key Populations
Ambassador Deborah L. Birx, MD
Using programme M&E data for Surveillance in Nepal: Challenges and Opportunities Name of Author(s): Biwesh Ojha(1)
Pakistan Last updated: July 2015.
UNESCO: More than Education!
Key Affected Populations
Community involvement in scaling up TB/HIV activities
Presentation Overview
Parinita Bhattacharjee, Giuliana J. Morales, Timothy M
China 2010 UNGASS Country Progress Report
From toward HIV Elimination with Boosted-Integrated Active HIV Case Management (B-IACM) in Cambodia Dr. Penh Sun LY, Director, NCHADS Presented.
Myanmar Last Update: November 2014.
Key Affected Populations
Needs Assessment Slides for Module 4
Data Hub for Asia-Pacific Review in slides Philippines
Bhutan Last updated: July 2018.
Comprehensive M&E Systems
Notes: Rapid assessments.
Illustrative Cluster Detection and Response Strategy
Stakeholder engagement and research utilization: Insights from Namibia
Review in slides Most-at-risk populations
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Serge Clotaire Billong Senior Lecturer / FMBS-UY1 USE OF RESEARCH EVIDENCE IN THE IMPLEMENTATION OF AIDS CONTROL PROGRAMS IN CAMEROON Serge Clotaire Billong Senior Lecturer / FMBS-UY1 National Coordinator SPSER / GTC/ CNLS-Cameroon

AGENDA INTRODUCTION Country Profile / HIV summary data Domains and stakeholders of HIV and AIDS research in Cameroon USE of DATA as evidence-base for prevention, care and treatment programs CONCLUSION

INTRODUCTION / COUNTRY PROFILE Central Africa: 24 000 000 inhabitants 2,7% prevalence of HIV(DHS 2018) 500 000 PLWHIV Prevalence of HIV among MSM: 20,6%(2016) Prevalence of HIV among sex workers: 24,3%(2016) New HIV infections in 2018 Adults 15-49 years 16 784 Youths 15-24 years 6 834 Nb persons on treatment: 284 000 (2019) Nb of annual deaths from AIDS : 17 766 (2018)

INTRODUCTION/ DOMAINS & RESEARCH STAKEHOLDERS Type of Research Themes Institutions Periodicity Epidemiological Surveys National Surveys DHS/CAMPHIA NACC/MoPH/ /NIS/ICAP 5 years HIV Sentinel Surveillance NACC / WHO/MoPH 2 – 3 years HIV Surveillance among key populations (IBBS)   03 – 4 years Surveillance of HIV resistance 1 year Other Research Specific Surveys Behavior among specific populations - Research on HIV impact Target on health personnel and others CIRCB Fundamental Research on HIV drug resistance Study of resistant viral strains Thematic Research Eg.. Among disabled persons ANRS NASA Survey CNLS Survey on unique code Programmatic mapping CHAMP/USAID JHU PREP  JHU Other Research topics in universities - Theses Miscellanous UNIVERSITIES

USE OF DATA Reliable Research data (1) : From all this research, much data and a lot of evidence has emerged, especially from operational research About 10 years ago, the national HIV program made little or no use of data emerging from research; the credibility of available research reports for decision-making in country was not clear In 2009, the HIV Monitoring and Evaluation Technical Working Group was put to place. This group provides a forum where researchers, faculty members, donors, UN partners, and persons living with or at risk of HIV gather to review research related data for decision making All parties involved have research capacity

USE OF DATA Reliable research data (2) : The group aims to validate research proposals and contribute to the implementation, validation and dissemination of research results that can be used for decision making By being implicated at every step of the research continuum, the stakeholders confidently accept the results Furthermore, we submit abstracts and manuscripts of research work to different peer reviewed journals for publication; with the contribution of our partners, particularly Johns Hopkins University Scientific publications being more reliable than even validated reports

USE OF DATA Place and example of use of research evidence Research results are mainly used during planning in the national HIV program For example, we notice a rejection of MSM status during the implementation of national prevention strategies in Cameroon. This being attributed to witchcraft practices among many other reasons The IBBS survey carried out in 2012 allowed us to estimate the size of this population in Cameroon. It was estimated to be up to 28 000 MSM with a very high HIV prevalence (44%) Heavily funded programs were put in place and the MSM were recognized as a key population in the National Strategic Plan(NSP)

USE OF DATA Place and examples of use of research evidence Also, the mapping of sex workers carried out with the assistance of the World Bank in 2017 brought to light vulnerable areas and targeted interventions were implemented Recent publications on the vulnerability of sex workers confronted police /uniformed men. Targeted interventions toward sensitization of uniformed men and magistrates were implemented Published studies showed that retention of PLHIV on treatment in the national program was very low. This led to recruitment of thousands of psycho–social workers to improve retention in care Recent results indicate that resistance to HIV is rising. With this evidence, advocacy and negotiations were undertaken to consider the implementation of HIV resistance testing during routine follow up of patients

USE OF DATA Place and examples of use of research evidence We now publish a quarterly epidemiological bulletin addressed to stakeholders of the national HIV program. Considering the value and increasing number of research carried out published in peer review international journals Research results have also attracted many funders who now assist the country on many research themes and also finance the implementation of interventions For example the Global Fund provided funds only after being showed scientific evidence

USE OF DATA How interventions that worked well and those that did not work were important for decision-making Very few studies are conducted in Cameroon to evaluate interventions that have been implemented Studies carried out are essentially impact assessments, epidemiological surveys or other studies to obtain targets and determine interventions sites A process evaluation of interventions is usually not carried out It is therefore difficult to know the determinants of the results obtained in case of success or failure, so as to improve on future interventions Or to document and disseminate best practices

USE OF DATA How interventions that worked well and those that did not work were important for decision-making Nevertheless we can note the following: An assessment of HIV rapid test results in 2014 showed a very high rate of errors amongst pregnant women. Almost 20% of errors (most of them pre-analytic), had all the consequences that we can imagine A decision was taken to widely scale up a proficiency testing program for HIV rapid diagnostic tests in the country A new assessment was done in 2018, showing a significant improvement in the quality of HIV rapid test results, with an error rate that decreased from 20% to 7%

USE OF DATA What are the "best" data for making decisions about programs? At present, we think that programs have routine data which is an important source of very little used strategic information Program impact and impact monitoring data should continue to be updated on a regular basis (DHS, IBBS, SSS, ...) on different sub populations

USE OF DATA What are the "best" data for making decisions about programs? Evaluative data of the interventions are cruelly lacking and need to be carried out For example, following the studies which showed that the retention of the patients was very low, a large number of psycho-social workers were recruited at a very high cost But the improvement in retention is slow. It would have been important to analyze or evaluate this intervention given its very high cost

CONCLUSION In Cameroon, Research results on HIV are consistently and regularly used for decision making Particularly during planning activities We strongly believe, we have a good experience on this HIV topic and, The successful use of research results is associated to the fact that stakeholders are involved at all levels (including strategic and operational) from inception to production and validation of results We are now being challenged by efforts to having a specific research agenda on HIV which include evaluative research

THANK YOU